Connect with us

Health

SARS-CoV-2’s resistance to remdesivir in vitro – News-Medical.Net

A new preprint research paper posted to the bioRxiv server discusses the emergence of mutations in the SARS-CoV-2 virus, allowing it to escape the effects of the…

Published

on

post featured image

With over 108 million reported infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide, and nearly 2.4 million deaths, the ongoing pandemic has jeopardized the physical, financial and emotional wellbeing of the global population over the past year. A new preprint research paper posted to the bioRxiv* server discusses the emergence of mutations in the SARS-CoV-2 virus, allowing it to escape the effects of the most commonly used antiviral drug, remdesivir.
In an effort…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending